Capture

PRODUCTS

  • ECT2’s SORBIX™ H Series is designed for applications requiring flow rates of up to 1,357 GPM per vessel, such as drinking water systems. Additional vessel trains can be added to achieve any required flow rate.

  • At ProPharma, our Cell and Gene Therapy consulting team offers a comprehensive and integrated approach to early-stage cell and gene therapy development. Our expert team provides a range of services, including IND/CTA preparation, manufacturing technology, safety and risk assessment, and development planning, to help our clients navigate the complex and ever-changing landscape of cell and gene therapy development.

  • Allogeneic CAR-T Cells Vs Autologous

    Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the major breakthroughs in cancer immunotherapy in the last decade. Clinical trials with autologous CAR-T cells have shown very promising results and led to the approval of numerous CAR-T cell therapies.

  • Material selection is the foundation for every successful medical device. In addition to performance properties, each material must be suitable for processing, compatibility with other device components, economics, and much more.

  • Digital services on a scale that is unique in the industry, including visual support with augmented reality, remote diagnosis via QR code, and visual spare parts search. The core is the myHERMA customer portal, in which the machine cockpit is also integrated - for a perfect overview of all ordered and installed devices.

WHITE PAPERS AND CASE STUDIES

NEWS